CVS Health's Q1 Bond Buys
CVS Health Diversifies Portfolio with New Stakes in Five Bond ETFs During Q1
Anonymous
Key Points
1
CVS Health owned about 0.12% of iShares 3-7 Year Treasury Bond ETF (IEI) as of its latest SEC filing, providing a precise measure of its stake in the ETF itself alongside the broader portfolio allocation.
2
In its Vanguard Short-Term Corporate Bond ETF (VCSH) position, CVS’s stake is complemented by a market detail: VCSH opened at $78.64 on Tuesday, underscoring contemporaneous trading activity around the ETF.
3
The fund iShares 20+ Year Treasury Bond ETF (TLT) has a notably large institutional base, with 73.33% of its stock owned by hedge funds and other institutional investors, illustrating the broader investor landscape around CVS’s TLT purchase.
4
For VCIT, CVS’s activity includes a market data touchpoint: the Vanguard Intermediate-Term Corporate Bond ETF opened at $81.71 on Tuesday, providing context for the fund’s recent activity alongside CVS’s own stake.
5
Within IEF, institutional ownership is dominant, with 81.48% of iShares 7-10 Year Treasury Bond ETF stock held by institutional investors and hedge funds, offering a broader market context for CVS’s 35,000-share purchase.
CVS Health made a major move into bond ETFs in the first quarter, opening new positions across five funds worth a combined roughly $41.2 million, according to Watchlist News. The largest bet was on iShares 3-7 Year Treasury Bond ETF (IEI), where CVS picked up 182,800 shares for about $21.68 million — making it the company's second-biggest holding at around 10% of its portfolio.
The moves signal a deliberate shift toward fixed-income exposure, spanning short-term corporate bonds to long-duration Treasuries. CVS spread its new stakes across funds from both iShares and Vanguard, covering maturities from under three years to over 20.
IEI Becomes CVS's Second-Largest Holding Overnight
The IEI position is CVS's headline move this quarter. The company bought 182,800 shares, valued at about $21.68 million, according to Watchlist News. That makes IEI roughly 10% of CVS's total portfolio. CVS now owns about 0.12% of the entire ETF, a precise measure of just how large this stake is relative to the fund itself.
IEI tracks intermediate U.S. Treasury bonds with maturities between three and seven years. It sits in the middle of the yield curve — not too short, not too long. That makes it a relatively conservative bet. CVS's decision to make it its second-largest holding suggests a preference for stability over yield.
Corporate Bond Funds Round Out the New Portfolio Bets
Beyond Treasuries, CVS also moved into corporate bond ETFs. It bought 120,000 shares of Vanguard Short-Term Corporate Bond ETF (VCSH) for about $9.51 million — roughly 4.5% of its portfolio and its eighth-largest position, per Watchlist News. VCSH opened at $78.64 on Tuesday, reflecting active trading around the fund. CVS also added 60,000 shares of Vanguard Intermediate-Term Corporate Bond ETF (VCIT) for about $4.97 million, landing it at 12th in the portfolio at 2.3%.
VCIT opened at $81.71 on Tuesday, according to Watchlist News. Together, the VCSH and VCIT stakes give CVS about $14.5 million in corporate bond exposure. Corporate bond ETFs carry slightly more risk than Treasuries but typically offer higher yields, suggesting CVS is balancing safety with a modest income boost.
Long-Duration Treasury Stakes Draw Heavy Institutional Crowd
CVS also stepped into the long end of the Treasury market. It bought 20,000 shares of iShares 20+ Year Treasury Bond ETF (TLT) for about $1.73 million. That is a smaller position — about 0.8% of the portfolio, ranking 18th. But TLT is already a crowded trade: 73.33% of the ETF is owned by hedge funds and other institutional investors, according to Watchlist News.
CVS also picked up 35,000 shares of iShares 7-10 Year Treasury Bond ETF (IEF) for roughly $3.34 million, making it 16th in the portfolio at about 1.6%. IEF is similarly dominated by large investors — 81.48% of its shares are held by institutional investors and hedge funds. CVS is joining a very institutional crowd with these longer-duration bets.
CVS's Bond ETF Strategy Points to a Defensive Playbook
Taken together, CVS's five new bond ETF positions total roughly $41.2 million. The bulk — about $25 million — sits in Treasury funds. The rest is split between short- and intermediate-term corporate bonds. This mix leans defensive. Treasuries are among the safest assets available. Adding them in size suggests CVS wants to protect capital, not chase returns.
CVS also opened other ETF positions in Q1, including stakes in Vanguard Long-Term Treasury ETF (VGLT) and Vanguard Intermediate-Term Treasury ETF (VGIT), according to Ticker Report. The VGIT purchase alone was 85,000 shares for about $5.06 million. The pattern is clear: CVS is building a broad, bond-heavy investment book with a strong lean toward U.S. government debt.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
19
Articles
2
Reach
21
A
AnonymousAuthor